Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.
Gallardo A, Molina A, Asenjo HG, Lopez-Onieva L, Martorell-Marugán J, Espinosa-Martinez M, Griñan-Lison C, Alvarez-Perez JC, Cara FE, Navarro-Marchal SA, Carmona-Sáez P, Medina PP, Marchal JA, Granados-Principal S, Sánchez-Pozo A, Landeira D. Gallardo A, et al. Among authors: navarro marchal sa. Oncogene. 2022 Jul;41(28):3611-3624. doi: 10.1038/s41388-022-02375-x. Epub 2022 Jun 9. Oncogene. 2022. PMID: 35680984
Silver Nanoparticles from Annona muricata Peel and Leaf Extracts as a Potential Potent, Biocompatible and Low Cost Antitumor Tool.
González-Pedroza MG, Argueta-Figueroa L, García-Contreras R, Jiménez-Martínez Y, Martínez-Martínez E, Navarro-Marchal SA, Marchal JA, Morales-Luckie RA, Boulaiz H. González-Pedroza MG, et al. Among authors: navarro marchal sa. Nanomaterials (Basel). 2021 May 12;11(5):1273. doi: 10.3390/nano11051273. Nanomaterials (Basel). 2021. PMID: 34066096 Free PMC article.
Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution.
Aguilera-Garrido A, Graván P, Navarro-Marchal SA, Medina-O'Donnell M, Parra A, Gálvez-Ruiz MJ, Marchal JA, Galisteo-González F. Aguilera-Garrido A, et al. Among authors: navarro marchal sa. Biomed Pharmacother. 2023 Jul;163:114828. doi: 10.1016/j.biopha.2023.114828. Epub 2023 May 8. Biomed Pharmacother. 2023. PMID: 37163783 Free article.
Progress and Hurdles of Therapeutic Nanosystems against Cancer.
Martín-Contreras M, Navarro-Marchal SA, Peula-García JM, Jódar-Reyes AB. Martín-Contreras M, et al. Among authors: navarro marchal sa. Pharmaceutics. 2022 Feb 10;14(2):388. doi: 10.3390/pharmaceutics14020388. Pharmaceutics. 2022. PMID: 35214119 Free PMC article. Review.
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.
Blaya-Cánovas JL, Griñán-Lisón C, Blancas I, Marchal JA, Ramírez-Tortosa C, López-Tejada A, Benabdellah K, Cortijo-Gutiérrez M, Cano-Cortés MV, Graván P, Navarro-Marchal SA, Gómez-Morales J, Delgado-Almenta V, Calahorra J, Agudo-Lera M, Sagarzazu A, Rodríguez-González CJ, Gallart-Aragón T, Eich C, Sánchez-Martín RM, Granados-Principal S. Blaya-Cánovas JL, et al. Among authors: navarro marchal sa. Mol Cancer. 2024 May 9;23(1):83. doi: 10.1186/s12943-024-01997-x. Mol Cancer. 2024. PMID: 38730475 Free PMC article.